Adrenoleukodystrophy (patient information): Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:


==What causes Adrenoleukodystrophy?==
==What causes Adrenoleukodystrophy?==
[[Adrenoleukodystrophy]] is passed down from parents to their children as an [[X-linked]] [[genetic trait]]. It therefore affects mostly [[males]], although some [[women]] who are [[Genetic carrier|carriers]] can have milder forms of the [[disease]]. It affects approximately 1 in 20,000 people from all races.
The [[condition]] results in the buildup of very-long-chain [[fatty acids]] in the [[nervous system]], [[adrenal gland]], and [[testes]], which disrupts normal activity. There are three major categories of [[disease]]:
*Childhood cerebral form -- appears in mid-childhood (at ages 4 - 8)
*Adrenomyelopathy -- occurs in men in their 20s or later in life
*Impaired [[adrenal gland]] function (called [[Addison disease]] or Addison-like [[phenotype]]) -- [[adrenal gland]] does not produce enough [[steroid hormones]]


==Who is at risk for Adrenoleukodystrophy?==
==Who is at risk for Adrenoleukodystrophy?==

Revision as of 20:55, 26 March 2010

For the WikiDoc page for this topic, click here

WikiDoc Resources for Adrenoleukodystrophy (patient information)

Articles

Most recent articles on Adrenoleukodystrophy (patient information)

Most cited articles on Adrenoleukodystrophy (patient information)

Review articles on Adrenoleukodystrophy (patient information)

Articles on Adrenoleukodystrophy (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adrenoleukodystrophy (patient information)

Images of Adrenoleukodystrophy (patient information)

Photos of Adrenoleukodystrophy (patient information)

Podcasts & MP3s on Adrenoleukodystrophy (patient information)

Videos on Adrenoleukodystrophy (patient information)

Evidence Based Medicine

Cochrane Collaboration on Adrenoleukodystrophy (patient information)

Bandolier on Adrenoleukodystrophy (patient information)

TRIP on Adrenoleukodystrophy (patient information)

Clinical Trials

Ongoing Trials on Adrenoleukodystrophy (patient information) at Clinical Trials.gov

Trial results on Adrenoleukodystrophy (patient information)

Clinical Trials on Adrenoleukodystrophy (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adrenoleukodystrophy (patient information)

NICE Guidance on Adrenoleukodystrophy (patient information)

NHS PRODIGY Guidance

FDA on Adrenoleukodystrophy (patient information)

CDC on Adrenoleukodystrophy (patient information)

Books

Books on Adrenoleukodystrophy (patient information)

News

Adrenoleukodystrophy (patient information) in the news

Be alerted to news on Adrenoleukodystrophy (patient information)

News trends on Adrenoleukodystrophy (patient information)

Commentary

Blogs on Adrenoleukodystrophy (patient information)

Definitions

Definitions of Adrenoleukodystrophy (patient information)

Patient Resources / Community

Patient resources on Adrenoleukodystrophy (patient information)

Discussion groups on Adrenoleukodystrophy (patient information)

Patient Handouts on Adrenoleukodystrophy (patient information)

Directions to Hospitals Treating Adrenoleukodystrophy (patient information)

Risk calculators and risk factors for Adrenoleukodystrophy (patient information)

Healthcare Provider Resources

Symptoms of Adrenoleukodystrophy (patient information)

Causes & Risk Factors for Adrenoleukodystrophy (patient information)

Diagnostic studies for Adrenoleukodystrophy (patient information)

Treatment of Adrenoleukodystrophy (patient information)

Continuing Medical Education (CME)

CME Programs on Adrenoleukodystrophy (patient information)

International

Adrenoleukodystrophy (patient information) en Espanol

Adrenoleukodystrophy (patient information) en Francais

Business

Adrenoleukodystrophy (patient information) in the Marketplace

Patents on Adrenoleukodystrophy (patient information)

Experimental / Informatics

List of terms related to Adrenoleukodystrophy (patient information)

Editor-in-Chief: Alexandra M. Palmer

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

What is Adrenoleukodystrophy?

Adrenoleukodystrophy describes several closely related inherited disorders that disrupt the breakdown (metabolism) of certain fats (very-long-chain fatty acids).

What are the symptoms of Adrenoleukodystrophy?

What causes Adrenoleukodystrophy?

Adrenoleukodystrophy is passed down from parents to their children as an X-linked genetic trait. It therefore affects mostly males, although some women who are carriers can have milder forms of the disease. It affects approximately 1 in 20,000 people from all races.

The condition results in the buildup of very-long-chain fatty acids in the nervous system, adrenal gland, and testes, which disrupts normal activity. There are three major categories of disease:

Who is at risk for Adrenoleukodystrophy?

How do I know I have Adrenoleukodystrophy?

When to seek urgent medical care

Treatment options

Where to find medical care for Adrenoleukodystrophy

Directions to Hospitals Treating Adrenoleukodystrophy

What to expect (Outlook/Prognosis)

Possible complications

Sources

Template:SIB Template:WH Template:WS